Hongmei M. Yong
84 West Huaihai Road
Xuzhou, 221002, China
Xuzhou, 221002, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Microprotein MP104 Promotes Malignant Progression of Colorectal Cancer Through Regulating Protein Translation.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 16, 2026
The role of IL-6 in tumor immunity and related research progress.
Journal: Cellular signalling
Published: December 07, 2025
PRMT5-Mediated Arginine Methylation of ACSL4 Attenuates Its Stability and Suppresses Ferroptosis in Renal Cancer.
Journal: Research (Washington, D.C.)
Published: April 27, 2025
IL-6 is a prognostic biomarker in patients with advanced esophageal squamous cell carcinoma received with PD-1 inhibitors.
Journal: Frontiers in immunology
Published: January 31, 2025
PRMT5-Mediated ALKBH5 Methylation Promotes Colorectal Cancer Immune Evasion via Increasing CD276 Expression.
Journal: Research (Washington, D.C.)
Published: September 29, 2024
FBXO22 promotes glioblastoma malignant progression by mediating VHL ubiquitination and degradation.
Journal: Cell death discovery
Published: August 24, 2023
Correction: Long noncoding RNA SH3PXD2A-AS1 promotes NSCLC proliferation and accelerates cell cycle progression by interacting with DHX9.
Journal: Cell death discovery
Published: August 21, 2023
PRMT2 promotes RCC tumorigenesis and metastasis via enhancing WNT5A transcriptional expression.
Journal: Cell death & disease
Published: January 16, 2023
Multicenter, single-arm, phase II study (CAP) of radiotherapy plus liposomal irinotecan followed by camrelizumab and anti-angiogenic treatment in advanced solid tumors.
Journal: Frontiers in immunology
Published: December 29, 2022
Last Updated: 09/26/2026